At-home vision monitoring app may improve patient care

November 13, 2017

New Orleans - Nov. 12, 2017 -- Patients with age-related macular degeneration or diabetic retinopathy who used a mobile application to test their vision at home got comparable results to in-office vision testing, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology. The findings suggest that the smartphone app may help patients take better care of their vision.

Ophthalmologists - physicians who specialize in medical and surgical eye care - have effective treatment options for AMD and diabetic retinopathy that slow or prevent vision loss. But treatment is most effective when it's given at the earliest signs of disease.

That's why ophthalmologists often ask their patients to check their vision at home with a test called the Amsler grid. It is a simple square on a sheet of paper containing a grid pattern and a dot in the middle. When used correctly, it can show problem spots in a patient's field of vision. However, research shows that patients often fail to use the Amsler grid between office visits, and patients find it difficult to use effectively.

The app, known as Checkup, is designed to engage patients with their health care. Patients use it to assess their vision as often as their ophthalmologist prescribes. The voice-activated app also sends reminders to a patient's device if they forget to test on schedule. Results of the test are sent in real time to a secure cloud-based data warehouse. The ophthalmologist can view the results, and contact the patient if they detect a deterioration in their vision.

Researchers at Northern California Retina Vitreous Associates in Mountain View, Calif., wanted to find out if a smartphone app can monitor patients' vision at home as accurately as vision testing in the ophthalmologist's office, so they asked 27 patients with either AMD or diabetic retinopathy to use the app for two months.

Patients tested their vision at home using the app, and were then re-tested in the office. There was strong agreement between the Checkup app and the in-office tests for both visual acuity and Amsler grid testing. Every patient reported that it was easy to use.

Linda Redington, 57, and her 83-year-old mother, Ethel Redington, were part of the study. They both have AMD. They said it was easy to set up on their phones and easy to use. Both Linda and Ethel tested their vision with a basic visual acuity test and the Amsler grid test.

"I never missed a day," Linda Redington said. "It was easy and it didn't take a big chunk out of the day. It took just five minutes."

She says that the Amsler grid test on the app was easier to use than the static, black dot on a piece of paper. Instead of wielding a pen and piece of paper, the app serves up a red, flashing light that she simply taps with her finger.

"We're excited about the potential of this technology to improve patient care," said lead researcher, Rahul N. Khurana, M.D. "More and larger studies are required to make sure it works as well as our small study showed. But we found that it encouraged patients to take a more active role in their care, and they found it easy to use."
-end-
About the American Academy of Ophthalmology

The American Academy of Ophthalmology is the world's largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, visit aao.org.

American Academy of Ophthalmology

Related Diabetic Retinopathy Articles from Brightsurf:

Promising discovery for patients with diabetic retinopathy
A study published in the journal Science has shed light on a cellular process that occurs in the retinas of people with diabetic retinopathy.

A vitamin A analog may help treat diabetic retinopathy
Diabetic retinopathy is a common complication of diabetes and a leading cause of blindness among the working-age population.

Scientists identify a potential treatment candidate for early type 2 diabetic retinopathy
Diabetic retinopathy is one of the main vascular complications of type 2 diabetes, and the most common cause of visual deterioration in adults.

Genes tell a story about diabetic kidney disease
Studying Finnish genes leads to unique revelations about the development of a serious complication of diabetes, and informs an ongoing genomic study of a Singaporean cohort as part of Singapore's Diabetes Study in Nephropathy and other Microvascular Complications (DYNAMO).

No need to draw blood -- smart photonic contact lens for diabetic diagnosis and retinopathy treatment
Sei Kwang Hahn and his research team from POSTECH developed a smart LED contact lens.

Scientists identify a possible new treatment for diabetic retinopathy
About 1 in 3 diabetic patients develops diabetic retinopathy (DR), which can impair vision and lead to blindness.

Asthma medication inhibits changes in diabetic retinopathy in type 1 diabetes mouse
A new study found the asthma medication montelukast (brand name Singulair) can inhibit early changes in diabetic retinopathy, the eye disease which develops due to diabetes, in a mouse model of type 1 diabetes.

Earlier detection of diabetic retinopathy with smartphone AI
Equipping a smartphone to capture retinal images and utilizing artificial intelligence to interpret them may help overcome barriers to ophthalmic screening for people with diabetes, new Kellogg Eye Center research shows.

Diabetic drug shown to reduce the risk of heart disease in non-diabetic patients
Metformin could reverse the harmful thickening of heart muscle that leads to cardiovascular disease, according to researchers at the University of Dundee.

CHOP researchers develop easy-to-implement predictive screening tool for retinopathy
A multi-hospital collaboration led by researchers at Children's Hospital of Philadelphia (CHOP) has found a simple method of determining which premature infants should be screened for retinopathy of prematurity (ROP).

Read More: Diabetic Retinopathy News and Diabetic Retinopathy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.